Vimentin Intermediate Filaments as Potential Target for Cancer Treatment.

Strouhalova, Katerina; Prechová, Magdalena; Gandalovicová, Aneta; Brábek, Jan; Gregor, Martin; Rosel, Daniel

Strouhalova, Katerina; Prechová, Magdalena; Gandalovicová, Aneta; Brábek, Jan; Gregor, Martin; Rosel, Daniel.

Afiliação

Strouhalova K; Department of Cell Biology, Charles University, Vinicná 7, 12843 Prague, Czech Republic.
Prechová M; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Prumyslová 595, 25242 Vestec u Prahy, Czech Republic.
Gandalovicová A; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 14220 Prague, Czech Republic.
Brábek J; Department of Cell Biology, Charles University, Vinicná 7, 12843 Prague, Czech Republic.
Gregor M; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Prumyslová 595, 25242 Vestec u Prahy, Czech Republic.
Rosel D; Department of Cell Biology, Charles University, Vinicná 7, 12843 Prague, Czech Republic.

Cancers (Basel) ; 12(1)2020 Jan 11.

Article em En | MEDLINE | ID: mdl-31940801

Palavras-chave

EMT; amoeboid; cancer drugs; cancer treatment; cell adhesion; invasion; mechanotransduction; mesenchymal; vimentin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google